Finally, the third signature (Im3) was composed of T-helper, antigen-presenting cells, and macrophages; 23.7% of tumor samples analyzed in this study were IDH-wt tumors; therefore, it is unknown which patterns are present in IDH mutant low-grade gliomas (45). The gene discussed is IDH2; the disease is neoplasm.